advances understanding lung cancer biology led observations specific genetic changes occur premalignant dysplasia observations occurred predominantly molecular studies resected lung tumors consequently fully representative biological abnormalities characterizing premalignant lesions individuals overt lung cancer studies premalignant epithelial cell biology chemoprevention needed patient subgroup initiative underway lung cancer specialized program research excellence spore grant awarded university colorado cancer center affiliated institutions national cancer institute identify participants early detection chemoprevention trials colorado spore initiated sputum cytology screening program targeting persons chronic obstructive pulmonary disease smoking histories NUMBER NUMBER months activation screening program sputum samples NUMBER participants evaluated NUMBER NUMBER subjects submitted specimens deemed adequate cytopathological interpretation NUMBER NUMBER provided sputum samples unsuitable cytodiagnosis participants submitted adequate samples NUMBER cytodiagnoses mild dysplasia NUMBER moderate severe dysplasia NUMBER presented carcinoma situ invasive carcinoma logistic regression modeling pursued determine selected demographic clinical status variables identified statistically significant predictors specific cytological outcome expected mild dysplasia moderate dysplasia forth apparent associations univariate multivariate analyses total number smoking history decreased severity cytodiagnosis individuals mild moderate dysplasia likely grades regular metaplasia lower based initial results colorado spore sputum cytology screening program conclude persons chronic obstructive pulmonary disease NUMBER smoking history high prevalence premalignant dysplasia detectable sputum cytology targeted research programs focusing lung cancer prevention early detection exploratory biomarker studies pack years pack years ex smokers pack years